Clinical Trials in Detroit

Showing 6981-7000 of 14,997 trials

Palm Tocotrienols in Chronic Hemodialysis (USA)

NCT02358967

Patients undergoing chronic hemodialysis are at increased risk for cardiovascular disease, attributed in part to increased oxidative stress, inflammation and dyslipidemia. Intervention with a naturally occurring dietary supplement may improve certain biomarkers of inflammation and oxidative stress and improve the lipid profile.

End Stage Renal DiseaseChronic Kidney Disease

Wayne State University280 participantsStarted Jun 2017

Detroit, Michigan, United States

COMPLETEDPhase 3< 1 mile

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

NCT01668784

The purpose of the study is to compare the clinical benefit, as measured by duration of overall survival, of Nivolumab vs. Everolimus in subjects with advanced or metastatic clear-cell renal cell carcinoma who have received prior anti-angiogenic therapy

Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma

Bristol-Myers Squibb821 participantsStarted Oct 2012

Fayetteville, Arkansas, United States • La Jolla, California, United States • Los Angeles, California, United States +165 more locations

Palm Tocotrienols in Chronic Hemodialysis (USA)

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

Find Trials by Condition in Detroit

Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort

Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Studying the Treatment Effect of Pirfenidone in Chronic Lung Allograft Dysfunction (STOP-CLAD)

Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)

Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

Patient-centered Development of the Cancer Support Community's Open to Options ®Chatbot Program

Trans-MAPP II Study of Urologic Chronic Pelvin Pain

A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

BRITEPath, Component 3 of iCHART (Integrated Care to Help At-Risk Teens)

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

Rare Genetic Disorders of the Breathing Airways

Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma Patients

Treatment for COVID-19 in High-Risk Adult Outpatients

Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy

Salivary Profiling in Infants Treated for Suspected Sepsis: The SPITSS Study